Matthew W. Davis

Insider Reports History

Location
C/O Aquestive Therapeutics, 30 Technology Drive, Warren, NJ
Signature
/s/ Lori Braender, as Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew W. Davis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aquestive Therapeutics, Inc. Chief Development Officer Common Stock 50K $280K $5.59 Nov 10, 2025 Direct
Aquestive Therapeutics, Inc. Chief Development Officer Non-Qualified Stock Option (right to buy) 50K Nov 10, 2025 Direct

Insider Reports Filed by Matthew W. Davis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AQST Aquestive Therapeutics, Inc. Nov 10, 2025 2 $0 4 Nov 12, 2025 Chief Development Officer
AQST Aquestive Therapeutics, Inc. Nov 3, 2025 0 $0 3 Nov 12, 2025 Chief Development Officer